Fermeture de la manchette vaginale dans l'hystérectomie robotique
The purpose of this study is to evaluate the impact of implementing different types of suturing materials and techniques of vaginal cuff closure in robotic assisted laparoscopic hysterectomy on cost, operative time and post operative surgical outcomes.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
Robotic assisted laparoscopic surgery is the fastest growing new modality in gynecologic surgery. Surgeons are adapting it to perform both benign and oncologic gynecologic procedures. Therefore, the fastest growing robotic procedure in the united states is hysterectomy.
The literature in laparoscopic hysterectomy, both robotic and non-robotic, reports a complication of vaginal closure disruption after hysterectomy higher than with abdominal surgery. Reasons hypothesized for this phenomenon include colpotomy (vaginal incision) technique, vaginal closure technique, and types of suture. At present, no further follow up studies have been done to test some of these hypothesis. In light of the rapid adoption of this approach to hysterectomy, more data on this issue will help the physician in counseling patients regarding complications, as well as helping surgeons choose materials and techniques in their hysterectomies which will diminish the chance for this unfortunate complication, which causes pain, hospitalization and excess morbidity after the original surgery.
Additionally, a parallel development of newer suturing materials, the so-called "barbed" self-anchoring sutures, typically fabricated from monofilament materials, have been reported used in laparoscopic hysterectomies in case series. The relative contribution of theses newer materials to the rates of cuff disruption is unknown.
The protocol proposes testing the null hypothesis that different suture materials and methods of closure do not cause a significant difference in the rates of vaginal cuff disruption after robotic assisted laparoscopic total hysterectomy.
Study design is a prospective randomized controlled trial. Patients will be blindly randomized to one of the 3 closure techniques using 3 different materials. Technique and material by necessity can not be blinded to the surgeon. Otherwise, standard surgical technique will be used. Followup in 2 and 6 weeks for clinical assessment will be performed. To asses the long term of cuff disruption, a 12 month interview will be also conducted. Data points will include operative time for closure, postoperative pain at 2 and 6 weeks, postoperative pain with urination/voiding at 2 and 6 weeks, spotting, bleeding and /or frank vaginal disruption documented at 2 and 6 weeks, and pain and presence of dyspareunia at 12 months will be assessed.
Cost associated with cuff closure will be calculated by addition of OR time and material cost.
Type d'étude
Type d'étude
Inscription (Réel)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Michigan
-
Detroit, Michigan, États-Unis, 48202
- Henry Ford Hospital
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Women scheduled for robotic assisted laparoscopic hysterectomy
Exclusion Criteria:
- Patients who will not consent.
- Hysterectomy due to malignant conditions.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Comparateur actif: V-lock suture
V-lock absorbable Wound Closure Device, by Covidien |
Vaginal cuff closure using V-loc sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using vicryl sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using Lapra-Ty II suture. This technique and material are standard of care for patients undergoing hysterectomy. |
|
Comparateur actif: Vicryl suture
Vicryl suture by Ethicon |
Vaginal cuff closure using V-loc sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using vicryl sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using Lapra-Ty II suture. This technique and material are standard of care for patients undergoing hysterectomy. |
|
Comparateur actif: Lapra-Ty II
Lapra-Ty II, Absorbable Suture Clip, by Ethicon |
Vaginal cuff closure using V-loc sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using vicryl sutures. This technique and material are standard of care for patients undergoing hysterectomy. Vaginal cuff closure using Lapra-Ty II suture. This technique and material are standard of care for patients undergoing hysterectomy. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Vaginal cuff dehiscence
Délai: 12 months
|
Postoperative inspection for vaginal cuff dehiscence |
12 months
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Complications
Délai: 6 weeks
|
Post-operative vaginal bleeding, bowel or urinary dysfunction |
6 weeks
|
|
Operative time costs
Délai: 1 year
|
Measurement of operative time and determination of unit cost per surgery |
1 year
|
|
Suturing material costs
Délai: 1 year
|
Comparison of the amount and type of suture utilized per surgery |
1 year
|
|
Operative suturing time
Délai: During surgery
|
Time to complete Vaginal cuff closure |
During surgery
|
|
Post operative pain
Délai: 6 weeks
|
Visual Analog Scale |
6 weeks
|
|
Vaginal bleeding/ spotting
Délai: 12 months
|
Presence of postoperative vaginal bleeding |
12 months
|
|
Resumption of sexual activity
Délai: 12 months
|
Time to resumption of intercourse |
12 months
|
|
Dyspareunia
Délai: 12 months
|
Assessment of Painful Intercourse |
12 months
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chercheur principal: David Eisenstein, MD, Henry Ford Health System
Publications et liens utiles
Publications générales
- AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL position statement: route of hysterectomy to treat benign uterine disease. J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):1-3. doi: 10.1016/j.jmig.2010.10.001. Epub 2010 Nov 6. No abstract available.
- Greenberg JA, Einarsson JI. The use of bidirectional barbed suture in laparoscopic myomectomy and total laparoscopic hysterectomy. J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):621-3. doi: 10.1016/j.jmig.2008.06.004. Epub 2008 Jul 10.
- Einarsson JI, Vellinga TT, Twijnstra AR, Chavan NR, Suzuki Y, Greenberg JA. Bidirectional barbed suture: an evaluation of safety and clinical outcomes. JSLS. 2010 Jul-Sep;14(3):381-5. doi: 10.4293/108680810X12924466007566.
- Siedhoff MT, Yunker AC, Steege JF. Decreased incidence of vaginal cuff dehiscence after laparoscopic closure with bidirectional barbed suture. J Minim Invasive Gynecol. 2011 Mar-Apr;18(2):218-23. doi: 10.1016/j.jmig.2011.01.002.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Réel)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimé)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- 6297
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .